AIDS Long-Acting Injection is Ebovitae Long-Acting Injection, which can cause adverse reactions such as headache and dizziness, and is contraindicated for use in pregnant women and nursing mothers, among others. Ebovitae long-acting injection is a drug that has been marketed for the treatment of Acquired Human Immunodeficiency Disease (AIDS) after being approved by China’s Drug Administration. It can be used in combination with other antiretroviral drugs to inhibit the replication of the acquired immunodeficiency virus. Common clinical adverse reactions known to occur with Ebovitae Injection include headache, dizziness, and diarrhea, while less common adverse reactions include elevated triglyceride and cholesterol and transaminase levels as well. Contraindications to the use of this product include pregnant and lactating women, lactating mothers infected with human immunodeficiency virus, and patients who are allergic to the components of this drug. This drug must be used regularly under the supervision of a doctor.